Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzydamine spray versus lozenges for acute sore throat in children
2022-003285-20Phase 4Completed
- Sponsor
- Angelini Pharma
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of benzydamine in acute pharyngitis (2 arms), sponsored by Angelini Pharma. Primary endpoint: Responder rate at 15 minutes after first dose. Started Jan 2023; status: completed.
02
Drugs
benzydamine
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on 2022-003285-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003285-20.